PharmEasy To Supplement Govt’s Effort To Accelerate Vaccination Drive

Mumbai : PharmEasy, a digital healthcare platform, is aiming to supplement the government’s effort, with the launch of one of the biggest vaccination rollouts in the country. It will further accelerate the vaccination drive, as they will be working towards leveraging their presence across India – over 80,000 partner retailers, 5,000 doctors and an impeccable pharma supply chain to enable the last-mile delivery of the vaccine.

The company aims to vaccinate over 3 crore families via 5,000 partner centres pan-India in the next few quarters, in a phased manner. This would consist of registration, setting up of vaccination centres (corporate setups, individual doctor clinics and nursing homes & hospitals), and ultimately the vaccination rollout.

“Once we have further clarity from the Government of India on the availability of vaccines, we will release the timeline for the start of the drive and as soon as the doses are available, we will reach out to registered individuals and assist them with their vaccination slots at a camp set up in their vicinity,” stated Dharmil Sheth, co-founder, PharmEasy.

Sheth added, “The response we have received is overwhelming, with over 50 lakh individuals and over 1,700 organizations across the length and breadth of the country, coming forward to make a commitment to vaccinate themselves and their respective families.”

The company stated that digital health is shaping up the delivery of health-related services to the masses and with the added boost of digital health solutions, the e-pharmacy industry will definitely grow.

E-pharmacy ventured in India recently and is still in its nascent stage, compared to globally, where the industry is growing at a steady 15% and is expected to be a $200 billion industry by 2025.

In the last year, due to the pandemic, the use of e-pharmacy services saw an increase by 2.5 times in India as per a white paper released by apex industry body, the Federation of Indian Chambers of Commerce & Industry (FICCI).

Sheth added that there is still a vast scope to leverage growth and innovation so that the load on the traditional medical infrastructure decreases especially now in the aftermath of the pandemic.

“The requirement is to create a robust healthcare system and ensure we reach a wider population by providing prompt, simple and easy access to medicines and other health-related products,” added Sheth.

LEAVE A REPLY

Please enter your comment!
Please enter your name here